{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:22:37Z","timestamp":1790144557814,"version":"4.0.1"},"reference-count":60,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"unspecified","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,1,29]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) is a global health concern and a major long-term complication of diabetes, yet its burden remains understudied in regions with limited epidemiological data. This study aimed to evaluate the prevalence of CKD and its associated risk factors in the Iranian adult population, stratified by diabetes status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Population-based cross-sectional study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Nationally representative survey across Iran (STEPS 2021).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>17\u2009607 adults aged \u226525 years with complete kidney function and albuminuria data, selected through systematic sampling with weighting to ensure national representativeness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>CKD was defined as an estimated glomerular filtration rate (eGFR) &lt;60\u2009mL\/min\/1.73 m\u00b2 (CKD-EPI equation) or urine albumin-to-creatinine ratio (UACR) \u226530\u2009mg\/g and categorised into four KDIGO (Kidney Disease: Improving Global Outcomes) 2024 risk groups for CKD progression. Logistic regression assessed the associations between CKD and sociodemographic, clinical and behavioural factors; multinomial logistic regression examined diabetes associations with KDIGO risk categories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The national prevalence of CKD was 11.9% (95% CI 11.2% to 12.6%), with 9.1% (8.5% to 9.9%) among individuals without diabetes and 28.6% (26.2% to 31.1%) among those with diabetes. According to KDIGO classification, 88.1% (87.4% to 88.8%) were at low risk, 9.0% (8.4% to 9.6%) at moderate risk, 2.0% (1.6% to 2.4%) at high risk and 0.9% (0.7% to 1.1%) at very high risk. Albuminuria was more prevalent than low eGFR in both groups with (22.5% (20.4% to 24.8%) vs 10.3% (8.7% to 12.1%)) and without (5.7% (5.2% to 6.3%) vs 4.3% (3.8% to 4.8%)) diabetes. Diabetes was more strongly linked to albuminuria than low eGFR and was progressively associated with higher risk categories (adjusted ORs (aORs) 2.41 (2.03\u20132.86) for moderate, 2.63 (1.74\u20133.97) for high, 3.93 (2.56\u20136.07) for very high vs low-risk). CKD prevalence was highest in northwest Iran, increased significantly with age, with a stronger association observed for low eGFR than albuminuria, and was associated with hypertension (aOR 2.41 (2.07\u20132.82)), dyslipidaemia (1.60 (1.31\u20131.94)), obesity (1.94 (1.59\u20132.36)), ischaemic heart disease (1.53 (1.25\u20131.87)) and physical inactivity (1.40 (1.20\u20131.62)). Higher socioeconomic status and education were associated with lower odds of CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CKD is a major burden, especially in individuals with diabetes, with regional and socioeconomic disparities. Addressing risk factors, integrating CKD into non-communicable disease surveillance and prioritising it in global health agendas, including the Sustainable Development Goals, are essential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-111078","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T15:27:53Z","timestamp":1770737273000},"page":"e111078","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and risk factors of chronic kidney disease among Iranian adults with and without diabetes: a cross-sectional study using STEPS 2021 national survey"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6463-4784","authenticated-orcid":false,"given":"Seyed Mohammad-Navid","family":"Ataei","sequence":"first","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golaleh","family":"Almasi","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameneh","family":"Kazemi","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Ahmadi","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Golestani","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Mahdi","family":"Rashidi","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7047-7638","authenticated-orcid":false,"given":"Negar","family":"Rezaei","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0105-3801","authenticated-orcid":false,"given":"Sina","family":"Azadnajafabad","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4241-1783","authenticated-orcid":false,"given":"Nazila","family":"Rezaei","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezou","family":"Dilmaghani-Marand","sequence":"additional","affiliation":[{"name":"Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfan","family":"Ghasemi","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Farzi","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moein","family":"Yoosefi","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Rezaee","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira","family":"Foroutan Mehr","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Nasserinejad","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Haghshenas","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arefeh","family":"Alipour Derouei","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Momen Nia Rankohi","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Djalalinia","sequence":"additional","affiliation":[{"name":"Development of Research and Technology Center, Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8288-4046","authenticated-orcid":false,"given":"Farshad","family":"Farzadfar","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"},{"name":"Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"2026021223253793000_16.2.e111078.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2021.11.003"},{"key":"2026021223253793000_16.2.e111078.2","doi-asserted-by":"crossref","first-page":"1501175","DOI":"10.3389\/fmed.2024.1501175","article-title":"Global, regional, and national burden inequality of chronic kidney disease, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"11","author":"Guo","year":"2024","journal-title":"Front Med"},{"key":"2026021223253793000_16.2.e111078.3","unstructured":"Global burden of disease (GBD) compare. n.d. Available: https:\/\/vizhub.healthdata.org\/gbd-compare\/"},{"key":"2026021223253793000_16.2.e111078.4","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.173"},{"key":"2026021223253793000_16.2.e111078.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61350-6"},{"key":"2026021223253793000_16.2.e111078.6","doi-asserted-by":"crossref","unstructured":"Rashidi M-M , Saeedi Moghaddam S , Azadnajafabad S , et al . Mortality and disability-adjusted life years in North Africa and Middle East attributed to kidney dysfunction: a systematic analysis for the Global Burden of Disease Study 2019. Clin Kidney J 2024;17. doi:10.1093\/ckj\/sfad279","DOI":"10.1093\/ckj\/sfad279"},{"key":"2026021223253793000_16.2.e111078.7","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1115833","article-title":"Trends of national and sub-national burden attributed to kidney dysfunction risk factor in Iran: 1990-2019","volume":"14","author":"Nejadghaderi","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026021223253793000_16.2.e111078.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.11.007"},{"key":"2026021223253793000_16.2.e111078.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30788-2"},{"key":"2026021223253793000_16.2.e111078.10","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2014.07.008"},{"key":"2026021223253793000_16.2.e111078.11","doi-asserted-by":"crossref","first-page":"1015902","DOI":"10.3389\/fpubh.2022.1015902","article-title":"Regional burden of chronic kidney disease in North Africa and Middle East during 1990-2019; Results from Global Burden of Disease study 2019","volume":"10","author":"Tabatabaei-Malazy","year":"2022","journal-title":"Front Public Health"},{"key":"2026021223253793000_16.2.e111078.12","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0140-6736(18)33197-0","article-title":"Iran in transition","volume":"393","author":"Danaei","year":"2019","journal-title":"Lancet"},{"key":"2026021223253793000_16.2.e111078.13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/joneph\/22.1.99","article-title":"The epidemiology of adult chronic kidney disease in a population-based study in Iran: prevalence and associated risk factors","volume":"22","author":"Safarinejad","year":"2009","journal-title":"J Nephrol"},{"key":"2026021223253793000_16.2.e111078.14","first-page":"109","article-title":"Prevalence of chronic kidney disease and its contributing risk factors in southern Iran: a cross-sectional adult population-based study","volume":"8","author":"Khajehdehi","year":"2014","journal-title":"Iran J Kidney Dis"},{"key":"2026021223253793000_16.2.e111078.15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/1744-9987.12716","article-title":"Prevalence of Chronic Kidney Disease in Iranian General Population: A Meta-Analysis and Systematic Review","volume":"22","author":"Bouya","year":"2018","journal-title":"Ther Apher Dial"},{"key":"2026021223253793000_16.2.e111078.16","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s40200-023-01298-y","article-title":"The national trend of the burden of Chronic Kidney Disease (CKD) in Iran from 1990 to 2019","volume":"22","author":"Khashayar","year":"2023","journal-title":"J Diabetes Metab Disord"},{"key":"2026021223253793000_16.2.e111078.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30045-3"},{"key":"2026021223253793000_16.2.e111078.18","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s40200-023-01308-z","article-title":"The diabetes cascade of care through the 14 years in Iran: findings of nationwide STEPS surveys 2007-2021","volume":"22","author":"Ameli","year":"2023","journal-title":"J Diabetes Metab Disord"},{"key":"2026021223253793000_16.2.e111078.19","doi-asserted-by":"crossref","first-page":"634","DOI":"10.34172\/aim.2022.99","article-title":"Protocol Design for Surveillance of Risk Factors of Non\u2013communicable Diseases During the COVID-19 Pandemic: An Experience from Iran STEPS Survey 2021","volume":"25","author":"Djalalinia","year":"2022","journal-title":"Arch Iran Med"},{"key":"2026021223253793000_16.2.e111078.20","unstructured":"STEPS manual. n.d. Available: https:\/\/www.who.int\/teams\/noncommunicable-diseases\/surveillance\/systems-tools\/steps\/manuals"},{"key":"2026021223253793000_16.2.e111078.21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2026021223253793000_16.2.e111078.22","doi-asserted-by":"publisher","DOI":"10.1016\/J.KINT.2023.10.018"},{"key":"2026021223253793000_16.2.e111078.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038423","article-title":"Prevalence of chronic kidney disease in adults in England: comparison of nationally representative cross-sectional surveys from 2003 to 2016","volume":"10","author":"Hounkpatin","year":"2020","journal-title":"BMJ Open"},{"key":"2026021223253793000_16.2.e111078.24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamainternmed.2022.6817","article-title":"Prevalence of Chronic Kidney Disease in China: Results From the Sixth China Chronic Disease and Risk Factor Surveillance","volume":"183","author":"Wang","year":"2023","journal-title":"JAMA Intern Med"},{"key":"2026021223253793000_16.2.e111078.25","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-11-201306040-00007"},{"key":"2026021223253793000_16.2.e111078.26","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-006-0024-x"},{"key":"2026021223253793000_16.2.e111078.27","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001307"},{"key":"2026021223253793000_16.2.e111078.28","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1097\/HJH.0000000000001836","article-title":"Salt intake among Iranian population: the first national report on salt intake in Iran","volume":"36","author":"Rezaei","year":"2018","journal-title":"J Hypertens"},{"key":"2026021223253793000_16.2.e111078.29","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.77"},{"key":"2026021223253793000_16.2.e111078.30","first-page":"75","article-title":"Methods of Estimating GFR - Different Equations Including CKD-EPI","volume":"32","author":"Florkowski","year":"2011","journal-title":"Clin Biochem Rev"},{"key":"2026021223253793000_16.2.e111078.31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12882-021-02484-x","article-title":"Prevalence of impaired renal function and determinants in the southwest of Iran","volume":"22","author":"Alvand","year":"2021","journal-title":"BMC Nephrol"},{"key":"2026021223253793000_16.2.e111078.32","doi-asserted-by":"crossref","unstructured":"Eftekharzadeh A , Hosseinpanah F , Valizadeh M , et al . Legacy of the Tehran Lipid and Glucose Study: Chronic Kidney Disease. Int J Endocrinol Metab 2018;16.","DOI":"10.5812\/ijem.84761"},{"key":"2026021223253793000_16.2.e111078.33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12882-022-02832-5","article-title":"Prevalence of chronic kidney diseases and its determinants among Iranian adults: results of the first phase of Shahedieh cohort study","volume":"23","author":"Dehghani","year":"2022","journal-title":"BMC Nephrol"},{"key":"2026021223253793000_16.2.e111078.34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176540","article-title":"Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study","volume":"12","author":"Sepanlou","year":"2017","journal-title":"PLoS One"},{"key":"2026021223253793000_16.2.e111078.35","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/jch.13980","article-title":"Prevalence of chronic kidney disease in Brazilians with arterial hypertension and\/or diabetes mellitus","volume":"22","author":"Comini","year":"2020","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2026021223253793000_16.2.e111078.36","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-020-02138-4","article-title":"Prevalence and risk factors of chronic kidney disease among Palestinian type 2 diabetic patients: a cross-sectional study","volume":"21","author":"Nazzal","year":"2020","journal-title":"BMC Nephrol"},{"key":"2026021223253793000_16.2.e111078.37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-63443-4","article-title":"Prevalence and Risk Factors of Chronic Kidney Disease among Type 2 Diabetes Patients: A Cross-Sectional Study in Primary Care Practice","volume":"10","author":"Jitraknatee","year":"2020","journal-title":"Sci Rep"},{"key":"2026021223253793000_16.2.e111078.38","first-page":"e1","article-title":"The prevalence of chronic kidney disease among type 2 diabetes mellitus patients in central South Africa","volume":"65","author":"Mhundwa","year":"2004","journal-title":"S Afr Fam Pract"},{"key":"2026021223253793000_16.2.e111078.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2016.03.020"},{"key":"2026021223253793000_16.2.e111078.40","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.pcd.2020.05.005","article-title":"The prevalence of chronic kidney disease and screening of renal function in type 2 diabetic patients in Finnish primary healthcare","volume":"14","author":"Hagn\u00e4s","year":"2020","journal-title":"Prim Care Diabetes"},{"key":"2026021223253793000_16.2.e111078.41","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s40200-023-01186-5","article-title":"Inequalities in prevalence of hypertension, prehypertension, anti-hypertensive coverage, awareness, and effective treatment in 429 districts of Iran; a population-based STEPS 2016 small area spatial estimation model","volume":"22","author":"Mohammadi","year":"2023","journal-title":"J Diabetes Metab Disord"},{"key":"2026021223253793000_16.2.e111078.42","doi-asserted-by":"crossref","first-page":"1043894","DOI":"10.3389\/fendo.2022.1043894","article-title":"The levels of BMI and patterns of obesity and overweight during the COVID-19 pandemic: Experience from the Iran STEPs 2021 survey","volume":"13","author":"Djalalinia","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026021223253793000_16.2.e111078.43","doi-asserted-by":"crossref","first-page":"15499","DOI":"10.1038\/s41598-023-42341-5","article-title":"Prevalence of plasma lipid abnormalities and associated risk factors among Iranian adults based on the findings from STEPs survey 2021","volume":"13","author":"Khanali","year":"2023","journal-title":"Sci Rep"},{"key":"2026021223253793000_16.2.e111078.44","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019030238"},{"key":"2026021223253793000_16.2.e111078.45","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018111166"},{"key":"2026021223253793000_16.2.e111078.46","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2014.07.002"},{"key":"2026021223253793000_16.2.e111078.47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/ndt\/gfad172","article-title":"Burden and quality of care index of chronic kidney disease: Global Burden of Disease analysis for 1990-2019","volume":"39","author":"Rashidi","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026021223253793000_16.2.e111078.48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158765","article-title":"Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"2026021223253793000_16.2.e111078.49","doi-asserted-by":"crossref","first-page":"108740","DOI":"10.1016\/j.jdiacomp.2024.108740","article-title":"Risk factors for chronic kidney disease in middle eastern patients with type 2 diabetes mellitus: A cross-sectional study using the KDIGO classification","volume":"38","author":"Farah","year":"2024","journal-title":"J Diabetes Complications"},{"key":"2026021223253793000_16.2.e111078.50","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-023-01202-x"},{"key":"2026021223253793000_16.2.e111078.51","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020030384"},{"key":"2026021223253793000_16.2.e111078.52","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1296"},{"key":"2026021223253793000_16.2.e111078.53","unstructured":"Guidance on global monitoring for diabetes prevention and control: framework, indicators and application. n.d. Available: https:\/\/cdn.who.int\/media\/docs\/default-source\/ncds\/ncd-surveillance\/guidance-on-global-monitoring-for-diabetes.pdf?sfvrsn=ccb261b8_4"},{"key":"2026021223253793000_16.2.e111078.54","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr599"},{"key":"2026021223253793000_16.2.e111078.55","unstructured":"Good health and well-being. n.d. Available: https:\/\/unstats.un.org\/sdgs\/report\/2023\/goal-03"},{"key":"2026021223253793000_16.2.e111078.56","unstructured":"Noncommunicable disease facility-based monitoring guidance. n.d. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240057067"},{"key":"2026021223253793000_16.2.e111078.57","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013040330"},{"key":"2026021223253793000_16.2.e111078.58","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2215\/CJN.03690316","article-title":"Strategies for BP Control in Developing Countries and Effects on Kidney Function","volume":"11","author":"Jun","year":"2016","journal-title":"CJASN"},{"key":"2026021223253793000_16.2.e111078.59","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2016-000256","article-title":"Chronic kidney disease in low-income to middle-income countries: the case for increased screening","volume":"2","author":"George","year":"2017","journal-title":"BMJ Glob Health"},{"key":"2026021223253793000_16.2.e111078.60","doi-asserted-by":"crossref","unstructured":"Badro DA . Chronic kidney disease management in developing countries. In: Handbook of Medical and Health Sciences in Developing Countries: Education, Practice, and Research. Springer, 2023: 1\u2013146.","DOI":"10.1007\/978-3-030-74786-2_27-1"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-111078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:26:10Z","timestamp":1770967570000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-111078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":60,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,10]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bmjopen-2025-111078"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-111078","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}